Authors: Manjubhashini Prabhuram, Santhiya Sekar, Malini Manivannan, Soundravalli Varadan, Vidyapoornam Nagarajan
The disease COVID-19 caused by SARS-CoV-2 that led to serious health problems since late 2019, and WHO announced as pandemic. The only diagnostic strategy available during pandemic was RT PCR used as the gold standard method, due to its high throughput procedure and high cost, the screening of patients would be difficult. Hence the antigen and antibody detecting rapid diagnostic kits were developed, that can be used as the point of care testing. The assessment of iFInDx COVID-19 IgM/IgG test kit was evaluated the sensitivity and specificity of the diagnostic kit with a total samples of 427 compared with ELISA and RT PCR method. Keywords: COVID19, RDT, Elisa, AgAb interaction, RTPCR
Open full article page